ConductScience.org, home

Paper8519652

Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.

Groen HJ and 6 others. Br J Cancer, 1995. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines. Papers, record 8519652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8519652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
PubMed
Journal
Br J Cancer
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
0.96
iCite
Revised in PubMed
2019-05-15
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Groen HJH J
2Sleijfer SS
3Meijer CC
4Kampinga HHH H
5Konings AWA W
6De Vries EGE G
7Mulder NHN H

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
CarboplatinMajor topic
Carcinoma, Small CellMajor topic
CisplatinMajor topic
Lung NeoplasmsMajor topic
Cell Survival
Combined Modality Therapy
DNA Damage
DNA, Neoplasm
Dose-Response Relationship, Radiation
Drug Synergism
Electrophoresis
Humans
Nucleic Acid Conformation
Radiation Tolerance
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13802100Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.Cancer Res1987https://conductscience.org/library/papers/3802100PubMed
27999772HMG domain proteins induce sharp bends in cisplatin-modified DNA.Biochemistry1994https://conductscience.org/library/papers/7999772PubMed
33549645Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data.Int J Radiat Oncol Biol Phys1987https://conductscience.org/library/papers/3549645PubMed
43562793Irradiation damage in chromatin isolated from V-79 Chinese hamster lung fibroblasts.Radiat Res1987https://conductscience.org/library/papers/3562793PubMed
53303163Radiosensitization in vitro by cis-diammine (1,1-cyclobutanedicarboxylato) platinum(II) (carboplatin, JM8) and ethylenediammine-malonatoplatinum(II) (JM40).Radiother Oncol1987https://conductscience.org/library/papers/3303163PubMed
62846161Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.Cancer Res1988https://conductscience.org/library/papers/2846161PubMed
72545337Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up.Cancer Res1989https://conductscience.org/library/papers/2545337PubMed
82756105Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses.Radiat Res1989https://conductscience.org/library/papers/2756105PubMed
92669136Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin.Semin Oncol1989https://conductscience.org/library/papers/2669136PubMed
102571657CHEF electrophoresis, a sensitive technique for the determination of DNA double-strand breaks.Int J Radiat Biol1989https://conductscience.org/library/papers/2571657PubMed
111967296In CHEF electrophoresis a linear induction of dsb corresponds to a nonlinear fraction of extracted DNA with dose.Int J Radiat Biol1990https://conductscience.org/library/papers/1967296PubMed
122302704Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation.Cancer Res1990https://conductscience.org/library/papers/2302704PubMed
13422420Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity.Int J Radiat Oncol Biol Phys1979https://conductscience.org/library/papers/422420PubMed
14575122Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammineplatinum (II).Int J Radiat Oncol Biol Phys1979https://conductscience.org/library/papers/575122PubMed
157275727Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy.Int J Radiat Oncol Biol Phys1981https://conductscience.org/library/papers/7275727PubMed
167198110Effect of cis-dichlorodiammine platinum II and X rays on mammalian cell survival.Int J Radiat Oncol Biol Phys1981https://conductscience.org/library/papers/7198110PubMed
177041539Criteria for analyzing interactions between biologically active agents.Adv Cancer Res1981https://conductscience.org/library/papers/7041539PubMed
183910216Carboplatin as a potentiator of radiation therapy.Cancer Treat Rev1985https://conductscience.org/library/papers/3910216PubMed
193704188Temporal interactions in the Lewis lung tumour between cytotoxic drugs and acute or fractionated radiotherapy.Radiother Oncol1986https://conductscience.org/library/papers/3704188PubMed
203737877Nuclear matrix proteins are crosslinked to transcriptionally active gene sequences by ionizing radiation.Radiat Res1986https://conductscience.org/library/papers/3737877PubMed

See all 32 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
41854291Cell-cycle-specific lesion evolution rather than inhibition of double-strand-break repair underpins cisplatin radiosensitization.Mol Oncol2026https://conductscience.org/library/papers/41854291PubMed
38003688Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance.Int J Mol Sci2023https://conductscience.org/library/papers/38003688PubMed
32218101Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma.Korean J Intern Med2021https://conductscience.org/library/papers/32218101PubMed
28451402Efficacy and safety of antitumor agents plus radiotherapy compared with radiotherapy alone for brain metastases from lung cancer.Mol Clin Oncol2017https://conductscience.org/library/papers/28451402PubMed
26991853DNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer.DNA Repair (Amst)2016https://conductscience.org/library/papers/26991853PubMed
24817947DNA microarray reveals ZNF195 and SBF1 are potential biomarkers for gemcitabine sensitivity in head and neck squamous cell carcinoma cell lines.Int J Clin Exp Pathol2014https://conductscience.org/library/papers/24817947PubMed
22621925Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways.J Biol Chem2012https://conductscience.org/library/papers/22621925PubMed
17245338Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer.Br J Cancer2007https://conductscience.org/library/papers/17245338PubMed
17084534Molecular mechanisms of resistance and toxicity associated with platinating agents.Cancer Treat Rev2007https://conductscience.org/library/papers/17084534PubMed
16369746Phase I study of cisplatin and irinotecan combined with concurrent hyperfractionated accelerated thoracic radiotherapy for locally advanced non-small cell lung carcinoma.Int J Clin Oncol2005https://conductscience.org/library/papers/16369746PubMed
15886299Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining.Mol Cancer Res2005https://conductscience.org/library/papers/15886299PubMed
12715170
Expression of apoptosis-related proteins and morphological changes in a rat tumor model of human small cell lung cancer prior to and after treatment with radiotherapy, carboplatin, or combined treatment.
Virchows Arch2003https://conductscience.org/library/papers/12715170PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8519652

GET https://conductscience.org/api/papers/v1/8519652/references?page=2